Kuehne + Nagel strengthens its position in the European market for pharma solutions
Logistics solutions for the pharma and healthcare industry are among the most important growth drivers for Kuehne + Nagel’s European overland business. With the extension of the European overland cross dock platform in Contern and the integration of telematics data of key providers Kuehne + Nagel strengthens its position in the European market for pharma solutions.
Uwe Hött, Senior Vice President Overland Europe at Kuehne + Nagel, said, “Industry specific services for customers from the pharma & healthcare industry mark a key factor of Kuehne + Nagel’s success story in overland business. The investment into our Luxembourg pharma platform and the integration of telematics data of qualified key transport partners contribute significantly towards our overall strategy for the pharma industry with a special focus on temperature controlled transportation for both FTL and LTL. The extension of the Contern facility will enhance providing industry leading services with increased capacity for our customers.“
The platform in Contern is part of Kuehne + Nagel’s KN PharmaChain. KN PharmaChain is a multi-modal logistics solution for temperature-controlled door-to-door transportation, which allows accurate traceability of the deliveries, and intensive, proactive risk management.
The facility offers a complete coverage to all European destinations with competitive lead times and an industry leading GDP certified infrastructure. The new platform increases the capacity for loading and unloading pharmaceutical products under temperature controlled warehousing conditions and in a completely closed environment. The GDP certified cross-dock is divided into a zone of 2°-8°C and one of 15-25°C with 4.000 square metres dedicated for the pharma sector.
Furthermore the platform has several features that guarantee the best environment for the handling of pharmaceutical products.